EXHIBIT 4.2
THIRD AMENDED AND RESTATED
STOCKHOLDERS AGREEMENT
THIRD AMENDED AND RESTATED STOCKHOLDERS AGREEMENT, dated as of March 27,
2000, by and among UNITED SURGICAL PARTNERS INTERNATIONAL, INC., a Delaware
corporation (the "COMPANY"), WELSH, CARSON, XXXXXXXX & XXXXX VII, L.P. ("WCAS")
and the several other stockholders named in Schedule I hereto (WCAS and such
other stockholders being hereinafter at times referred to individually as a
"STOCKHOLDER" and collectively as the "STOCKHOLDERS").
WHEREAS, the Company and the Stockholders are parties to that certain
Second Amended and Restated Stockholders Agreement dated as of November 17, 1999
(the "STOCKHOLDERS AGREEMENT");
WHEREAS, the Company and each of the Stockholders desire to amend and
restate the Stockholders Agreement and to make certain arrangements among
themselves with respect to the matters set forth herein;
NOW, THEREFORE, in consideration of the premises and of the mutual
covenants and agreements herein contained, the parties hereto hereby agree that
the Stockholders Agreement shall be amended and restated as follows:
SECTION I. VOTING AGREEMENT. (a) At each annual or special stockholders
meeting called for such purpose, and whenever the stockholders of the Company
act by written consent with respect to election of directors, each Stockholder
agrees to vote or otherwise give such Stockholder's consent in respect of all
shares of capital stock of the Company (whether now or hereafter acquired) owned
by such Stockholder or as to which such Stockholder is entitled to vote, and the
Company shall take all necessary and desirable actions within its control, in
order to cause the election to the Board of Directors of the Company (i) the
CHIEF EXECUTIVE OFFICER of the Company, which individual will initially be
Xxxxxx Xxxxx; (ii) for so long as FFT PARTNERS I, L.P. and FFT Executive
Partners I, L.P. (together, "FFT Partners") collectively maintain ownership of
not less than 50% of the securities purchased by FFT Partners under the
Securities Purchase Agreement dated as of October 26, 1998 among the Company and
the several other parties named therein (or securities into which such
securities are converted, exchanged or reclassified), ONE INDIVIDUAL DESIGNATED
BY FFT PARTNERS and which individual shall be acceptable to WCAS in its
reasonable discretion. Such individual shall be appointed to the Board of
Directors on or before October 30, 1998 and Xxxxxx Xxxxxx shall be FFT Partners'
initial designee; and (iii) for so long as Baylor Health Services ("Baylor") and
entities to which Baylor may transfer its membership interest in Texas Health
Ventures Group L.L.C. ("THVGl") under Section 4.1(a) of the Second Amended and
Restated Regulations of THVGl dated as of June 1, 1999 (each such entity being a
"Permitted Baylor Transferee"), collectively maintain ownership of not less than
50% of the outstanding principal of the Convertible Subordinated Promissory Note
(the "Note") issued to Baylor under the Contribution and Purchase Agreement
dated as of May 11, 1999 among Baylor and the several other parties named
therein (or 50% of the aggregate securities into which the Note, directly or
indirectly, is converted, exchanged or reclassified), ONE INDIVIDUAL DESIGNATED
BY BAYLOR who is an officer of Baylor Health Care System at or above the level
of senior vice president. Such individual shall be appointed to the
1
Board of Directors on or before June 2, 1999 and Xxxxx Xxxxxx shall be Baylor's
initial designee.
(b) The Board of Directors shall meet on at least a quarterly basis unless
otherwise agreed by the Board. The Company will reimburse all such directors for
travel expenses reasonably incurred in connection with attending meetings of the
Board.
SECTION 2. INVESTOR TRANSFER RESTRICTIONS. (a) Each of the Stockholders
listed on Schedule I hereto under the heading "Investors" (the "Investors")
shall be entitled at any time to transfer (x) the shares of capital stock of the
Company owned by such Investor by will or by the laws of descent and
distribution, (y) up to 10% of the shares of capital stock of the Company owned
by such Investor by gift to such Investor's spouse, lineal descendants, parents
or siblings (or to a trust for the benefit of any of the foregoing) or (z) in
the case of Baylor, the shares of capital stock of the Company owned by Baylor
to any Permitted Baylor Transferee; PROVIDED that any such transferee shall
agree in writing with the Company to be bound by, and to comply with, all
applicable provisions of this Agreement and to be deemed to be an Investor for
purposes of this Agreement. Except for such transfers by will or by the laws of
descent and distribution or by gift as described in clauses (x) and (y) above or
such transfers to a Permitted Baylor Transferee as described in clause (z)
above, each Investor shall not be entitled to sell, pledge or otherwise transfer
shares of capital stock of the Company unless such Investor complies with the
provisions of Sections 3 and 4 below.
SECTION 3. RIGHT OF FIRST REFUSAL. Subject to the provisions of Section 2
above, an Investor (a "Selling Investor" for purposes of this Section 3) may
sell for cash all or any portion of the capital stock of the Company held by him
(whether now or hereafter acquired) at any time, pursuant to a bona fide offer
from a third party, subject to such Selling Investor's compliance with the
following provisions:
(a) The Selling Investor shall promptly deliver a notice of intention to
sell (a "Sale Notice") to the Company setting forth in reasonable detail the
capital stock of the Company to be sold (the "Subject Securities"), the identity
of the proposed purchaser and the proposed purchase price and terms of sale
(including a copy of any written offer or indication of interest).
(b) Upon receipt of a Sale Notice from the Selling Investor, the Company
shall have the first right and option to elect to purchase at the price and on
the terms stated in the Sale Notice, all or part of the number of the Subject
Securities. In the event that the Company shall elect to purchase all or part of
the Subject Securities, the Company shall so notify the Selling Investor within
20 days (the "Company Option Period") after the receipt by the Company of the
Sale Notice. Any such election shall be made by written notice (a "Company
Notice of Election") to the Selling Investor.
(c) If the Company Notice of Election with respect to the Subject
Securities shall have been received as aforesaid by the Selling Investor, the
Selling Investor shall sell such Subject Securities to the Company at the price
and on the terms stated in the Sale Notice. The closing of such sale of Subject
Securities shall take place at the offices of the Company no later than 20 days
following the expiration of the Company Option Period (or upon the expiration of
2
such longer period if required by law), or such other place and earlier date as
may be agreed by all parties to the transaction. At such closing the Selling
Investor shall deliver a certificate or certificates for the Subject Securities
to be sold, accompanied by stock powers with signatures guaranteed and all
necessary stock transfer stamps affixed, against receipt of the purchase price
therefor by certified or official bank check in New York Clearing House Funds or
by wire transfer of immediately available funds.
(d) Any Subject Securities not sold pursuant to the provisions of this
Section 3 may be sold (in compliance with Section 4 below) to the person
identified in the related Sale Notice for a period of 60 days following the
expiration of the Company Option Period or to any person or persons at a price
not lower than the price specified in the Sale Notice and on other terms not
materially more favorable to the purchaser than those specified in the Sale
Notice. Any Subject Securities not sold by such 60th day shall again be subject
to the restrictions contained in this Agreement.
SECTION 4. RIGHT OF CO-SALE. Any Stockholder (for purposes of this Section
4, a "Selling Stockholder"), subject to compliance with the provisions of
Sections 2 and 3 above (if applicable), may sell all or any portion of the Class
A Common Stock held by him (whether now or hereafter acquired), subject to such
Stockholder's compliance with the following provisions:
(a) Such Selling Stockholder shall promptly deliver a notice of intention
to sell (a "Co-Sale Notice") to the Company and to each Stockholder setting
forth the number of shares of Class A Common Stock to be sold (the "Co-Sale
Securities") and the proposed purchase price and terms of sale, except that no
Co-Sale Notice need be given by any Selling Stockholder exercising any right to
sell securities in response to a Co-Sale Notice delivered pursuant to this
paragraph (a). Upon receipt of the Co-Sale Notice, each Stockholder shall have
the right and option to elect to sell, at the price and on the terms stated in
the Co-Sale Notice, all or part of that number of shares of Class A Common Stock
which is equal to the product obtained by multiplying (i) the aggregate number
of shares of Class A Common Stock covered by the proposed sale by (ii) a
fraction, the numerator of which is the number of shares of Class A Common Stock
at the time owned by such Stockholder and the denominator of which is the number
of shares of Class A Common Stock at the time owned by all the Stockholders. Any
such election shall be made by written notice (a "Co-Sale Notice of Election")
to the Selling Stockholder and the Company within 10 business days after receipt
by such Stockholder of the Co-Sale Notice. Thereupon, the Selling Stockholder
shall not sell any of the Co-Sale Securities (i) except at the price and on the
terms stated in its Co-Sale Notice and (ii) if a Stockholder shall have
delivered a Co-Sale Notice of Election in respect thereof as aforesaid, unless
such Stockholder shall have been afforded the opportunity to sell the shares in
respect of which such Co-Sale Notice of Election shall have been delivered, at
said price and on said terms.
(b) Any Co-Sale Securities not sold pursuant to the provisions of (a)
above shall again be subject to the restrictions contained in this Agreement and
shall not thereafter be sold, except in compliance with the applicable
provisions of this Agreement.
(c) Upon electing to participate in a proposed sale pursuant to paragraph
(a) above, each Stockholder (i) shall deliver to the Company, as its agent, for
transfer to the proposed acquiror, one or more certificates, duly endorsed for
transfer or accompanied by stock
3
transfer powers duly endorsed for transfer, with all stock transfer taxes paid
and stamps affixed, which represent the number of shares of Class A Common Stock
that such Stockholder shall have so elected to sell and (ii) shall not be
subject to Sections 2 and 3 hereof, if applicable.
(d) The stock certificate or certificates delivered by each Stockholder to
the Company pursuant to paragraph (c) above shall be transferred by the Company
to the acquiror in consummation of the sale of the Class A Common Stock pursuant
to the terms and conditions specified in the Co-Sale Notice, and the Company
shall promptly thereafter remit to such Stockholder that portion of the proceeds
to which such Stockholder is entitled by reason of such participation.
(e) Notwithstanding the foregoing references in this Section 4 to shares
of Class A Common Stock, if all of the shares of the Company's Class A Common
Stock have been converted into shares of the Company's Common Stock, $.01 par
value ("Common Stock"), pursuant to subparagraph 3B of Section II of Article IV
of the Company's Certificate of Incorporation, as amended, then this Section 4
shall be applicable in its entirety to sales of such shares of Common Stock.
SECTION 5. LEGEND ON STOCK CERTIFICATES. Each certificate representing
shares of capital stock purchased by any Stockholder or issued in exchange of or
upon conversion of any of the securities purchased thereby shall conspicuously
bear the following legend until such time as the shares represented thereby are
no longer subject to the provisions hereof:
"THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO THE
TERMS AND CONDITIONS OF A STOCKHOLDERS AGREEMENT, DATED AS OF APRIL
30, 1998, AS AMENDED, AMONG THE ISSUER AND THE OTHER PARTIES
THERETO. COPIES MAY BE OBTAINED AT NO COST BY WRITTEN REQUEST MADE
BY THE HOLDER OF RECORD OF THIS CERTIFICATE TO THE COMPANY ."
The Company covenants that it shall keep a copy of this Agreement on
file at the address listed in Section 11 for the purpose of furnishing copies to
the holders of record of shares of capital stock of the Company.
SECTION 6. DURATION OF AGREEMENT. This Agreement shall terminate upon the
earliest to occur of (i) the tenth anniversary of the date hereof, (ii) the
consummation of an initial public offering registered under the Securities Act
of 1933, as amended, of shares of Common Stock, par value $.01, of the Company,
(iii) the consummation of any sale. transfer or other disposition of all or
substantially all the capital stock or assets of the Company for cash, or (iv)
with respect to any Stockholder, the date on which such Stockholder no longer
owns any shares of capital stock of the Company.
SECTION 7. REPRESENTATIONS AND WARRANTIES. Each Stockholder represents and
warrants to the Company and the other Stockholders as follows:
4
(a) The execution, delivery and performance of this Agreement by such
Stockholder will not violate any provision of law, any order of any court or
other agency of government, or any provision of any indenture, agreement or
other instrument to which such Stockholder or any of its or his properties or
assets is bound, or conflict with, result in a breach of or constitute (with due
notice or lapse of time or both) a default under any such indenture, agreement
or other instrument, or result in the creation or imposition of any lien, charge
or encumbrance of any nature whatsoever upon any of the properties or assets of
such Stockholder.
(b) This Agreement has been duly executed and delivered by such
Stockholder and constitutes the legal, valid and binding obligation of such
Stockholder, enforceable in accordance with its terms.
SECTION 8. HEADINGS. Headings of articles, sections and paragraphs of this
Agreement are inserted for convenience of reference only and shall not affect
the interpretation or be deemed to constitute a part hereof.
SECTION 9. SEVERABILITY. In the event that anyone or more of the
provisions contained in this Agreement or in any other instrument referred to
herein shall, for any reason, be held to be invalid, illegal or unenforceable,
such illegality, invalidity or unenforceability shall not affect any other
provisions of this Agreement.
SECTION 10. BENEFITS OF AGREEMENT. Nothing expressed by or mentioned in
this Agreement is intended or shall be construed to give any person other than
the parties hereto and their respective successors and permitted assigns any
legal or equitable right, remedy or claim under or in respect of this Agreement
or any provision herein contained, this Agreement and all conditions and
provisions hereof being intended to be and being for the sole and exclusive
benefit of the parties hereto and their respective successors and permitted
assigns. Subject to compliance with the terms of this Agreement, each
Stockholder shall have the right to assign its interests hereunder to any
transferee of the capital stock of the Company; PROVIDED that such transferee
shall agree in writing with the parties hereto to be bound by, and to comply
with, all applicable provisions of this Agreement and to be deemed to be a
Stockholder for purposes of this Agreement.
SECTION 11. NOTICES. Any notice or other communications required or
permitted hereunder shall be deemed to be sufficient and received if contained
in a written instrument delivered in person or by courier or duly sent by first
class certified mail, postage prepaid, or by facsimile addressed to such party
at the address or facsimile number set forth below:
(1) if to the Company, to:
United Surgical Partners International, Inc.
00000 Xxxxxxx Xxxx
Xxxxx 000 Xxxxx
Xxxxxx, XX 00000
Facsimile: 000-000-0000
Attention: Chief Executive Officer
5
(2) if to any other Stockholder, to the address of such Stockholder
appearing in Schedule I hereto;
or, in any case, at such other address or facsimile number as shall have been
furnished in writing by such party to the other parties hereto. All such
notices, requests, consents and other communications shall be deemed to have
been received (a) in the case of personal or courier delivery, on the date of
such delivery, (b) in the case of mailing, on the fifth business day following
the date of such mailing and (c) in the case of facsimile, when received.
SECTION 12. MODIFICATION. Except as otherwise provided herein, neither
this Agreement nor any provision hereof may be modified, changed, discharged or
terminated except by an instrument in writing signed by the Company, WCAS, FFT
Partners and the holders of the majority of the aggregate voting power of shares
of capital stock (on an as-converted basis) of the Company held by the
Management Stockholders; PROVIDED, HOWEVER, that no modification or amendment
shall be effective to reduce the percentage of the shares of capital stock of
the Company the consent of the holders of which is required under this Section
12; PROVIDED FURTHER, that no such amendment or modification shall be effective
without Baylor's consent if such amendment or modification affects Baylor any
differently than it affects other holders of Investor Shares. Notwithstanding
the foregoing, the Company may amend this Agreement without the consent of the
Stockholders solely to add stockholders to Schedule I hereto (which stockholders
shall be included in the definition of "Investors" hereunder).
SECTION 13. COUNTERPARTS. This Agreement may be executed in any number of
counterparts, and each such counterpart hereof shall be deemed to be an original
instrument, but all such counterparts together shall constitute but one
agreement.
SECTION 14. GOVERNING LAW. This Agreement shall be governed by,
enforceable under, and construed in accordance with the laws of the State of
Delaware.
[Signature pages follow]
6
IN WITNESS WHEREOF, each of the parties hereto has executed this Agreement
as of the day and year first above written.
UNITED SURGICAL PARTNERS INTERNATIONAL, INC.
By /s/ XXXXXX XXXXX
Xxxxxx Xxxxx
Chief Executive Officer
MANAGEMENT STOCKHOLDERS:
/s/ XXXXXX XXXXX
Xxxxxx Xxxxx
/s/ XXX XXXXXXX
Xxx Xxxxxxx
/s/ XXXXXX XXXXX
Xxxxxx Xxxxx
/s/ XXXXXXX XXXXX
Xxxxxxx Xxxxx
/s/ XXXXXXX XXXXXX
Xxxxxxx Xxxxxx (with respect to all
shares of capital stock acquired after
June 26, 1998)
/s/ XXXXXXX XXXXXXXX
Xxxxxxx Xxxxxxxx (with respect to all
shares of capital stock acquired after
July 31, 1998)
7
FFT PARTNERS I, L.P.
By: Xxxxxx Xxxxxxx Xxxxxxxx & Co., LLC
General Partner
By: /s/ XXXXXX X. XXXXXX
Xxxxxx X. Xxxxxx
General Partner
FFT EXECUTIVE PARTNERS I, L.P.
By: Xxxxxx Xxxxxxx Xxxxxxxx & Co., LLC
General Partner
By: /s/ XXXXXX X. XXXXXX
Xxxxxx X. Xxxxxx
General Partner
M. XXXXXX XXXXX TRUST
/s/ M. XXXXXX XXXXX
M. Xxxxxx Xxxxx, Trustee
/s/ XXXXXXXXX X. XXXXX
Xxxxxxxxx X. Xxxxx, Trustee
CALVER FUND, INC.
By: /s/ XXXX X. XXXXXXXX
Xxxx X. Xxxxxxxx, President
/s/ XXXXX XXX XXXXXX
Xxxxx Xxx Xxxxxx
8
NGKE/USPI PARTNERS
By: /s/ XXXXXX XXXXXX
Xxxxxx Xxxxxx, Managing Partner
L & W CO.
By: /s/ XXXXXX X. XXXXXXX
Xxxxxx X. Xxxxxxx, Vice-President &
Trust Officer
/s/ XXXXXX XXXXXXXXXX
Xxxxxx Xxxxxxxxxx
RIVID LLC
By: /s/ XXXXX XXXXXXXXXX
Xxxxx Xxxxxxxxxx, Manager
/s/ XXXX XXXXXXX
Xxxx Xxxxxxx
CGJR II, L.P.
By: CGJR Capital Management, Inc.,
General Partner
By: /s/ XXXXXXXXXXX XXXXX
Xxxxxxxxxxx Xxxxx, Jr., President
CGJR/MF III, L.P.
By: CGJR Capital Management, Inc.,
General Partner
By: /s/ XXXXXXXXXXX XXXXX, JR.
Xxxxxxxxxxx Xxxxx, Jr., President
9
/s/ XXXXXXX XxXXXXXX
Xxxxxxx XxXxxxxx
/s/ XXXXX XXXXXX
Xxxxx Xxxxxx
/s/ XXXXXXXX XXXXXX
Xxxxxxxx Xxxxxx
/s/ XXXXX XXXXXX
Xxxxx Xxxxxx
/s/ XXXXXXX X. XXXXXXXX
Xxxxxxx X. Xxxxxxxx
Tenants in Common with Xxxx X. Xxxxxxxx
/s/ XXXX X. XXXXXXXX
Xxxx X. Xxxxxxxx
Tenants in Common with
Xxxxxxx X. Xxxxxxxx
/s/ XXX X. XXXXX
Xxx X. Xxxxx
/s/ XXXXXX X. XXXXXXX
Xxxxxx X. Xxxxxxx
/s/ XXXXXXX X. XXXXXX
Xxxxxxx X. Xxxxxx
/s/ XXXXX X. XXXXXXX
Xxxxx X. Xxxxxxx
/s/ XXXXXXX XXXXXX
Xxxxxxx Xxxxxx
00
/x/ XXXXXXX XxXXX
Xxxxxxx XxXxx
/s/ XXXXX XXX
Xxxxx Xxx
/s/ XXXXXX XXXXXXXXXX
Xxxxxx Xxxxxxxxxx
/s/ XXXXXX XXXXXX
Xxxxxx Xxxxxx
/s/ XXXXX XXXXXXXX
Xxxxx Xxxxxxxx
/s/ XXXX XXXXXXXX
Xxxx Xxxxxxxx
/s/ XXX X'XXXXXXXX
Xxx X'Xxxxxxxx
/s/ XXXXXXX XXXXXXX
Xxxxxxx Xxxxxxx
/s/ XXXXXX X. XXXXXX
Xxxxxx X. Xxxxxx
BAYLOR HEALTH CARE SYSTEM FOUNDATION
/s/ M. XXXXXXX XXXXXX
M. Xxxxxxx Xxxxxx
Executive Vice President
11
WCAS STOCKHOLDERS:
WELSH, CARSON, XXXXXXXX & XXXXX VII, L.P.
By: WCAS VII Partners, L.P.
General Partner
By: /s/ XXXXXXXX X. RATHER
Xxxxxxxx X. Rather
General Partner
WCAS CAPITAL PARTNERS III, L.P.
By: WCAS CP III Associates, L.L.C.
General Partner
By: /s/ XXXXXXXX X. RATHER
Xxxxxxxx X. Rather
General Partner
WCAS HEALTHCARE PARTNERS, L.P.
By: WCAS HC Partners
General Partner
By: /s/ XXXXXXXX X. RATHER
Xxxxxxxx X. Rather
Attorney-in-Fact
Xxxxxxx X. Xxxxx
Xxxxxxx X. Xxxxxx
Xxxxx X. Xxxxxxxx
Xxxxxxx X. Xxxxx
Xxxxxx X. Xxxx
Xxxxxxx X. Xxxxxx
Xxxxx XxxXxxxx
Xxxxxx X. XxXxxxxxx
D. Xxxxx Xxxxxxx
Xxxxxx X. Xxxxxxxxx
Xxxxxxx X. xxXxxxxx
Xxxx X. Xxxxxxx
By: /s/ XXXXXXXX X. RATHER
12
Xxxxxxxx X. Rather
Attorney-in-Fact
/s/ XXXXXX XXXXXX
Xxxxxx Xxxxxx
13
SCHEDULE I -- STOCKHOLDERS
1. Investors
a. Management Stockholders
Xxxxxx Xxxxx
Xxx Xxxxxxx
Xxxxxx Xxxxx
Xxxxxxx Xxxxx
Xxxxxxx Xxxxxx (with respect to all shares of capital stock
acquired after June 26, 1998)
Xxxxxxx Xxxxxxxx (with respect to all shares of capital stock
acquired after July 31, 1998)
c/o United Surgical Partners International, Inc.
00000 Xxxxxxx Xxxx
Xxxxx 000 Xxxxx
Xxxxxx, XX 00000
Facsimile: 000-000-0000
14
b.
FFT Partners I, L.P.
FFT Executive Partners I, L.P.
c/o Ferrer Xxxxxxx
Xxxxxxxx & Co., LLC
00 Xxxxxxxxx Xxxxxx
Xxxxxxxxx, XX 00000
Facsimile: 203-532-8016
M. Xxxxxx Xxxxx Trust
Calver Fund, Inc.
Xxxxx Xxx Xxxxxx
NGKE/USPI Partners
L & W Co.
Xxxxxx Xxxxxxxxxx
Rivid LLC
Xxxx Xxxxxxx
CGJR II, L.P.
CGJR/MF III, L.P.
Xxxxxxx XxXxxxxx
Xxxxx Xxxxxx
Xxxxxxxx Xxxxxx
Xxxxx Xxxxxx
Xxxxxxx X. & Xxxx X. Xxxxxxxx
Xxx X. Xxxxx
Xxxxxxx Xxxxxx (with respect to the share of Class A Common Stock
acquired on June 26, 1998)
Xxxxxx X. Xxxxxxx
Xxxxxxx X. Xxxxxx
Xxxxx X. Xxxxxxx
Xxxxxxx Xxxxxx
Xxxxxxx XxXxx
Xxxxx Xxx
Xxxxxx Xxxxxxxxxx
Xxxxxxx Xxxxxxxx (with respect to the share of Class A Common Stock
acquired on July 31, 1998)
Xxxxxx Xxxxxx
Xxxxx Xxxxxxxx
Xxxx Xxxxxxxx
Xxx X'Xxxxxxxx
Xxxxxxx Xxxxxxx
Xxxxxx X. Xxxxxx
15
Baylor HealthCare System Foundation
0000 Xxxxxx Xxxxxx
Xxxxxx, Xxxxx 00000
Attention: Xxxxxxx X. Xxxxxx, Chief Financial Officer
Facsimile: (000) 000-0000
2. WCAS Stockholders
Welsh, Carson, Xxxxxxxx & Xxxxx VII, L.P.
WCAS Healthcare Partners, L.P.
WCAS Capital Partners III, L.P.
Xxxxxxx X. Xxxxx
Xxxxxxx X. Xxxxxx
Xxxxx X. Xxxxxxxx
Xxxxxxx X. Xxxxx
Xxxxxx X. Xxxx
Xxxxxx X. XxXxxxxxx
Xxxxx XxxXxxxx
Xxxxxx X. Xxxxxxxxx
Xxxxxxx xxXxxxxx
Xxxx X. Xxxxxxx
Xxxxxxx X. Xxxxxx
X. Xxxxx Maskesy
Xxxxxx Xxxxxx
c/o Welsh, Carson, Xxxxxxxx & Xxxxx
000 Xxxx Xxxxxx - Xxxxx 0000
Xxx Xxxx, XX 00000-0000
Facsimile: 000-000-0000
16
